AtCor Medical Holdings Limited (AtCor Medical) is a medical device company, engaged in the design, manufacture and marketing of medical devices for use in cardiovascular management. It principally develops and markets the SphygmoCor system, which measures central blood pressures noninvasively at the heart. Additionally, the SphygmoCor systems are widely used in the pharmaceutical clinical trials in many fields of medicine, that have an interest in cardiovascular disease. The company has three wholly owned subsidiaries and AtCor Medical conducts its US operations through AtCor Medical Inc. the company has an established distribution network in Europe and in many Asia-Pacific countries through a network of domestic distributors. AtCor Medical operates in Australia, New Zealand, Asia, Europe and North America and it is headquartered in New South Wales, Australia.